Methods for Exploring Heterogeneity in Meta-Analysis
暂无分享,去创建一个
[1] Á. Atallah,et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. , 2002, The Cochrane database of systematic reviews.
[2] Alex J. Sutton,et al. Methods for Meta-Analysis in Medical Research , 2000 .
[3] Alex J. Sutton,et al. Publication and related biases: a review , 2000 .
[4] I Olkin,et al. Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses. , 2000, Statistics in medicine.
[5] S Duval,et al. Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis , 2000, Biometrics.
[6] J. L. Tang,et al. Misleading funnel plot for detection of bias in meta-analysis. , 2000, Journal of clinical epidemiology.
[7] M. Limburg,et al. Calcium antagonists for acute ischemic stroke. , 2000, The Cochrane database of systematic reviews.
[8] A J Sutton,et al. Publication and related biases. , 2000, Health technology assessment.
[9] T. Sheldon,et al. Relation between hostility and coronary heart disease , 1999, British medical journal.
[10] I Olkin,et al. Diagnostic statistical procedures in medical meta-analyses. , 1999, Statistics in medicine.
[11] D. Moher,et al. The effectiveness of glucocorticoids in treating croup: meta-analysis , 1999, The Western journal of medicine.
[12] S Greenland,et al. Random-effects meta-analyses are not always conservative. , 1999, American journal of epidemiology.
[13] R. Dersimonian,et al. Resolving discrepancies between a meta-analysis and a subsequent large controlled trial. , 1999, JAMA.
[14] F Song,et al. Exploring heterogeneity in meta-analysis: is the L'Abbé plot useful? , 1999, Journal of clinical epidemiology.
[15] D. Spiegelman,et al. Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. , 1999, American journal of epidemiology.
[16] E. Ernst,et al. Artemether for severe malaria: a meta-analysis of randomized clinical trials. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] H. V. van Houwelingen,et al. Investigating underlying risk as a source of heterogeneity in meta-analysis. , 1999, Statistics in medicine.
[18] Christopher H. Schmid,et al. Exploring Heterogeneity in Randomized Trials Via Meta-Analysis , 1999 .
[19] C H Schmid,et al. An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials. , 1998, Statistics in medicine.
[20] L. Stewart,et al. Individual patient data meta-analysis in cancer. , 1998, British Journal of Cancer.
[21] S. Thompson,et al. Detecting and describing heterogeneity in meta-analysis. , 1998, Statistics in medicine.
[22] Christopher H Schmid,et al. Summing up evidence: one answer is not always enough , 1998, The Lancet.
[23] S D Walter,et al. Variation in baseline risk as an explanation of heterogeneity in meta-analysis. , 1997, Statistics in medicine.
[24] S G Thompson,et al. Investigating underlying risk as a source of heterogeneity in meta-analysis. , 1997, Statistics in medicine.
[25] George Davey Smith,et al. Meta-analysis: Beyond the grand mean? , 1997, BMJ.
[26] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[27] G. Grégoire,et al. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. , 1997, The New England journal of medicine.
[28] J. Bailar. The promise and problems of meta-analysis. , 1997, The New England journal of medicine.
[29] Cindy Farquhar,et al. 3 The Cochrane Library , 1996 .
[30] C H Schmid,et al. Large trials vs meta-analysis of smaller trials : How do their results compare ? , 1996 .
[31] Douglas G Altman,et al. The relation between treatment benefit and underlying risk in meta-analysis , 1996, BMJ.
[32] M. McIntosh,et al. The population risk as an explanatory variable in research synthesis of clinical trials. , 1996, Statistics in medicine.
[33] J. Slattery,et al. A systematic review of the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. , 1996, Stroke.
[34] J. Zalcberg,et al. The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.
[35] J. Villar,et al. Predictive ability of meta-analyses of randomised controlled trials , 1995, The Lancet.
[36] C S Berkey,et al. A random-effects regression model for meta-analysis. , 1995, Statistics in medicine.
[37] C H Schmid,et al. Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. , 1995, Journal of clinical epidemiology.
[38] C Anello,et al. Exploratory or analytic meta-analysis: should we distinguish between them? , 1995, Journal of clinical epidemiology.
[39] C. Begg,et al. Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.
[40] S G Thompson,et al. Systematic Review: Why sources of heterogeneity in meta-analysis should be investigated , 1994, BMJ.
[41] S Greenland,et al. Invited commentary: a critical look at some popular meta-analytic methods. , 1994, American journal of epidemiology.
[42] C S Berkey,et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. , 1994, JAMA.
[43] U. Helfenstein,et al. Fluoride varnishes (Duraphat): a meta-analysis. , 1994, Community dentistry and oral epidemiology.
[44] E. Antman,et al. Advantages and limitations of metaanalytic regressions of clinical trials data. , 1992, The Online journal of current clinical trials.
[45] S. Senn,et al. IMPORTANCE OF TRENDS IN THE INTERPRETATION OF AN OVERALL ODDS RATIO IN THEMETA-ANALYSIS OF CLINICAL TRIALS. AUTHOR'S REPLY , 1994 .
[46] S Senn,et al. Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials. , 1994, Statistics in medicine.
[47] F. Song,et al. Cholesterol lowering and mortality: the importance of considering initial level of risk. , 1993, BMJ.
[48] J P Pignon,et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. , 1992, The New England journal of medicine.
[49] P. Gøtzsche,et al. Meta-analysis of second-line antirheumatic drugs: sample size bias and uncertain benefit. , 1992, Journal of clinical epidemiology.
[50] H Kragt,et al. Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials. , 1992, Statistics in medicine.
[51] S G Thompson,et al. The potential and limitations of meta-analysis. , 1991, Journal of epidemiology and community health.
[52] T C Chalmers,et al. A comparison of statistical methods for combining event rates from clinical trials. , 1989, Statistics in medicine.
[53] R F Galbraith,et al. A note on graphical presentation of estimated odds ratios from several clinical trials. , 1988, Statistics in medicine.
[54] K A L'Abbé,et al. Meta-analysis in clinical research. , 1987, Annals of internal medicine.
[55] R. Light,et al. Accumulating evidence from independent studies: what we can win and what we can lose. , 1987, Statistics in medicine.
[56] K. Bailey,et al. Inter-study differences: how should they influence the interpretation and analysis of results? , 1987, Statistics in medicine.
[57] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[58] H. Morgenstern. Uses of ecologic analysis in epidemiologic research. , 1982, American journal of public health.
[59] N. Breslow,et al. Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .